当前位置:首页 - 行情中心 - 博济医药(300404) - 财务分析 - 现金流量表

博济医药

(300404)

  

流通市值:27.27亿  总市值:37.48亿
流通股本:2.81亿   总股本:3.86亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金384,396,444.29175,844,429.62680,449,708.78462,123,525.16
  收到其他与经营活动有关的现金23,992,185.2913,519,862.4646,414,128.3735,251,464.96
  经营活动现金流入小计408,388,629.58189,364,292.08726,863,837.15497,374,990.12
  购买商品、接受劳务支付的现金183,515,192.3883,683,514.53292,605,111.08208,630,653.22
  支付给职工以及为职工支付的现金161,596,469.8180,047,494.51324,269,736.97244,423,256.8
  支付的各项税费18,023,165.117,563,464.6638,957,921.126,910,217.31
  支付其他与经营活动有关的现金24,008,534.859,241,122.7644,250,680.1933,450,960.56
  经营活动现金流出小计387,143,362.15180,535,596.46700,083,449.34513,415,087.89
  经营活动产生的现金流量净额21,245,267.438,828,695.6226,780,387.81-16,040,097.77
二、投资活动产生的现金流量:
  收回投资收到的现金4,749,117.81749,117.8119,347,918.4615,548,168.46
  取得投资收益收到的现金839,399.97208,664.113,020,785.722,004,056.3
  处置固定资产、无形资产和其他长期资产收回的现金净额2,7501,370456,6205,740
  收到的其他与投资活动有关的现金272,000,00055,000,000679,100,000501,900,000
  投资活动现金流入小计277,591,267.7855,959,151.92701,925,324.18519,457,964.76
  购建固定资产、无形资产和其他长期资产支付的现金9,495,812.363,932,554.1129,352,753.9225,235,191.88
  投资支付的现金1,280,430-44,125,00038,125,000
  支付其他与投资活动有关的现金404,100,000182,100,000695,300,000642,800,000
  投资活动现金流出小计414,876,242.36186,032,554.11768,777,753.92706,160,191.88
  投资活动产生的现金流量净额-137,284,974.58-130,073,402.19-66,852,429.74-186,702,227.12
三、筹资活动产生的现金流量:
  吸收投资收到的现金14,044,736.465,840,171.324,203,927.321,613,512.2
  其中:子公司吸收少数股东投资收到的现金--849,765.37368,300
  取得借款收到的现金43,189,7001,000,0008,135,356.137,575,356.13
  收到其他与筹资活动有关的现金126,445.3840,795.76395,480.53142,028.8
  筹资活动现金流入小计57,360,881.846,880,967.0812,734,763.989,330,897.13
  偿还债务支付的现金41,954,914.161,000,00072,289,925.6646,291,080.46
  分配股利、利润或偿付利息支付的现金720,315.45378,656.968,458,887.087,925,382.13
  其中:子公司支付给少数股东的股利、利润--875,000875,000
  支付其他与筹资活动有关的现金1,971,441.12983,990.9618,969,471.7117,851,844.91
  筹资活动现金流出小计44,646,670.732,362,647.9299,718,284.4572,068,307.5
  筹资活动产生的现金流量净额12,714,211.114,518,319.16-86,983,520.47-62,737,410.37
四、汇率变动对现金及现金等价物的影响-119,795.01-41,860.08457,881.81-317,404.61
五、现金及现金等价物净增加额-103,445,291.05-116,768,247.49-126,597,680.59-265,797,139.87
  加:期初现金及现金等价物余额268,558,630.83268,558,630.83395,156,311.42395,156,311.42
  期末现金及现金等价物余额165,113,339.78151,790,383.34268,558,630.83129,359,171.55
补充资料:
  净利润17,560,429.1-30,657,467.22-
  资产减值准备13,366,516.57-23,892,167.61-
  固定资产和投资性房地产折旧12,437,222.4-23,532,955.45-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧12,437,222.4-23,532,955.45-
  无形资产摊销567,819.13-989,054.98-
  长期待摊费用摊销6,073,762.7-3,661,888.7-
  处置固定资产、无形资产和其他长期资产的损失--213,678.75-
  固定资产报废损失4,491.93-76,873.43-
  公允价值变动损失-914,273.99--1,058,690.69-
  财务费用901,318.79-3,186,407.41-
  投资损失-301,173.62--1,979,446.48-
  递延所得税-4,488,306.8--19,099,725.59-
  其中:递延所得税资产减少-4,677,422.95--18,209,077.67-
    递延所得税负债增加189,116.15--890,647.92-
  存货的减少-56,271,127.01-8,235,961.49-
  经营性应收项目的减少-47,644,764.79--108,310,906.97-
  经营性应付项目的增加78,962,251.88-60,078,199.36-
  不涉及现金收支的投资和筹资活动金额其他项目526,664.74-2,978,209.65-
  现金的期末余额165,113,339.78-268,558,630.83-
  减:现金的期初余额268,558,630.83-395,156,311.42-
  现金及现金等价物的净增加额-103,445,291.05--126,597,680.59-
公告日期2025-08-272025-04-262025-04-262024-10-26
审计意见(境内)标准无保留意见
TOP↑